Trading Signals: SONN Stock Price Prediction and Forecast (Mon. Aug. 24, 2015 - Thu. Apr. 30, 2020)(Sonnet BioTherapeutics Holdings, Inc.)
| SONN latest price $106.6000 (-6.82%) ($106.6000 - $124.2500) on Wed. Jun. 29, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4% (three month average) | RSI | 33 | Latest Price | $106.6000(-6.82%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | SONN declines -2.2% a day on average for past five trading days. | Weekly Trend | SONN declines -4.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support SONN advance at 0% a week (0% probability) IWC(16%) IWN(16%) QQQ(16%) SDY(16%) SKYY(16%) | Factors Impacting SONN price | SONN will decline at least -2% in a week (0% probabilities). VCSH(-26%) LQD(-20%) TLT(-18%) VCIT(-15%) CEMB(-14%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2% (StdDev 4%) | Hourly BBV | 0 () | Intraday Trend | -4.7% | | | |
|
Resistance Level | $122.89 | 5 Day Moving Average | $115.02(-7.32%) | 10 Day Moving Average | $118.9(-10.34%) | 20 Day Moving Average | $122.89(-13.26%) | To recent high | -52.9% | To recent low | 0% | Market Cap | $981m | | | | Sonnet BioTherapeutics Holdings, Inc. engages in the development of biologic drugs with enhanced single or bispecific mechanisms. Its technology utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. The company was founded on April 1, 2020 and is headquartered in Princeton, New Jersey. |